Latest total liabilities for SLGL: $7.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for SLGL is $7.1M as of March 2026. That compares with $6.9M in the prior-year period — up 3.7% year over year. Investors often review this figure alongside Sol-Gel Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, SLGL's total liabilities moved from $6.9M to $7.1M — a 3.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sol-Gel Technologies's operating scale or balance-sheet position.
A total liabilities figure of $7.1M for SLGL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting SLGL's total liabilities ($7.1M), review year-over-year change from $6.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Sol-Gel Technologies's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.